As the New Year unfolds, dance enthusiasts and art lovers can kick off 2025 with a dynamic showcase of new performances in the heart of the Hamptons. The inaugural Dance Out East, presented in ...

If your lot in life is to visit the most beautiful museums and galleries from around the globe, then boy do we have a treat ...

As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The ...

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) was downgraded by Guggenheim from a “buy” rating to a “neutral” rating ...

Guggenheim analyst Yatin Suneja downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a $20 price target Don't Miss Our New Year's ...

In the digital realm, the guggenheim-bilbao.eus website recorded a total of 2.893.452 visits and 10.850.342 page views in ...

Vistra leads surge in nuclear power plant operators, outperforming tech sector with record gains and analyst predictions for ...

Despite barely 2% below the all-time record of 2023, the Guggenheim Museum Bilbao achieved great results in 2024 thanks to the support of the public. The best months of the Guggenheim Museum Bilbao’s ...

Erik af Klint, the artist's great-grandnephew and foundation board chair, said the gallery’s representation would lead to the ...

Guggenheim analysts reiterated their Buy rating and a $48 price target for Madison Square Garden Entertainment (NYSE:MSGE), positioning the company as their top investment idea for 2025. Despite ...

Investing.com -- Guggenheim named Madison Square Garden Sports Corp (NYSE:MSGS) its "best idea" for 2025 given strong secular ...

Guggenheim New York is an icon of adventurous originality. Experience special exhibitions in our iconic, spiraling rotunda, plus highlights from our collection by Picasso, Degas, and Van Gogh.